Recorded Chinese product: 桂利嗪片桂利嗪片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

氟桂利嗪是一种在国家药监局注册认定的药品。该药品含有氟桂利嗪-97cfbc82等成分。

该药品关联的活性成分包括:氟桂利嗪Fugui Liqin。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:广州康和药业有限公司Chinese legal name: 广州康和药业有限公司。

您可以探索含有相同成分的其他药品:氟桂利嗪-97cfbc82成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 桂利嗪片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 氟桂利嗪Fugui Liqin.

Manufacturers recorded for this product: 广州康和药业有限公司Chinese legal name: 广州康和药业有限公司.

Explore other medicines containing the same ingredient: 氟桂利嗪 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 桂利嗪片Recorded Chinese product: 桂利嗪片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 25mgX40片/盒Recorded Chinese specification: 25mgX40片/盒

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 广州康和药业有限公司Chinese legal name: 广州康和药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H44021699

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H44021699

Manufacturer

Chinese legal name: 广州康和药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H44021699

生产企业

广州康和药业有限公司(国产)

适应症

1.脑供血不足,椎动脉缺血,脑血栓形成后等。|2.耳鸣,脑晕。|3.偏头痛预防。|4.癫痫辅助治疗。

用法用量

口服,每次25~50mg ,每日2次。

不良反应

1.中枢神经系统的不良反应有: |①嗜睡和疲惫感为最常见; |②长期服用者可以出现抑郁症,以女性病人较常见;|③锥体外系症状,表现为不自主运动、下颔运动障碍、强直等。多数用药3周后出现,停药后消失。老年人中容易发生; |④少数病人可出现失眠,焦虑等症状。|2.消化道症状表现为:胃部烧灼感,胃纳亢进,进食量增加,体重增加。|3.其他:少数病人可出现皮疹,口干,溢乳,肌肉酸痛等症状。但多为短暂性,停药可以缓解。

禁忌

有本药物过敏史,或有抑郁症病史时以及急性脑出血性疾病禁用。

注意事项

1.疲惫症状逐步加重者应当减量或停药。|2.严格控制药物应用剂量,当应用维持剂量达不到治疗效果或长期应用出现锥体外系症状时,应当减量或停服药。|3.患有帕金森病等锥体外系疾病时,应当慎用本制剂。|4.驾驶员和机械操作者慎用,以免发生意外。

贮藏

遮光,密封,在阴凉干燥处保存。

规格

25mgX40片/盒

证据Evidence

  • 批准文号: 国药准字H44021699
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.